BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10732528)

  • 41. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma].
    Fares N; Péron JM
    Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of primary hepatocellular carcinoma treatment: an 8-year experience with 368 patients in Thailand.
    Pawarode A; Tangkijvanich P; Voravud N
    J Gastroenterol Hepatol; 2000 Aug; 15(8):860-4. PubMed ID: 11022825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conventional Ethiodized Oil Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma: Contemporary Single-Center Review of Clinical Outcomes.
    Casadaban LC; Minocha J; Bui JT; Knuttinen MG; Ray CE; Gaba RC
    AJR Am J Roentgenol; 2016 Mar; 206(3):645-54. PubMed ID: 26901023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health-related quality of life of patients with intermediate hepatocellular carcinoma after liver resection or transcatheter arterial chemoembolization.
    Xie ZR; Luo YL; Xiao FM; Liu Q; Ma Y
    Asian Pac J Cancer Prev; 2015; 16(10):4451-6. PubMed ID: 26028113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
    Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
    World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers.
    Rodríguez de Lope C; Reig M; Matilla A; Ferrer MT; Dueñas E; Mínguez B; F Castroagudín J; Ortiz I; Pascual S; Lledó JL; Gallego A; Arenas JI; Aracil C; Forne M; Muñoz C; Pons F; Sala M; Iñarrairaegui M; Martin-Llahi M; Andreu V; Garre C; Rendón P; Fuentes J; Crespo J; Rodríguez M; Bruix J; Varela M;
    Med Clin (Barc); 2017 Jul; 149(2):61-71. PubMed ID: 28279536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
    Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptom concerns and quality of life in hepatobiliary cancers.
    Sun V; Ferrell B; Juarez G; Wagman LD; Yen Y; Chung V
    Oncol Nurs Forum; 2008 May; 35(3):E45-52. PubMed ID: 18467279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Living With Hepatocellular Carcinoma Near the End of Life: Family Caregivers' Perspectives.
    Hansen L; Rosenkranz SJ; Wherity K; Sasaki A
    Oncol Nurs Forum; 2017 Sep; 44(5):562-570. PubMed ID: 28820518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Best supportive care of hepatocellular carcinoma].
    Spangenberg HC; Thimme R; Von Weizsäcker F; Blum HE
    Internist (Berl); 2004 Jul; 45(7):777-85. PubMed ID: 15160245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of Locoregional Tumor Therapy for Patients with Hepatocellular Carcinoma and Transjugular Intrahepatic Portosystemic Shunts.
    Padia SA; Chewning RH; Kogut MJ; Ingraham CR; Johnson GE; Bhattacharya R; Kwan SW; Monsky WL; Vaidya S; Hippe DS; Valji K
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):913-21. PubMed ID: 25373795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Resection and postoperative multidisciplinary treatment for hepatocellular carcinoma with massive portal venous tumor thrombus-a single-center experience].
    Kashiwazaki M; Hama N; Takiuchi D; Noguchi K; Hata T; Asukai K; Hamano R; Yoshioka S; Miki H; Tsujie M; Yano K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1675-7. PubMed ID: 24393885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
    Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
    World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver resection for hepatocellular carcinoma in patients with hematological malignancies.
    Lin HC; Yang YS; Teng CJ; Shen CH; Jan YG; Cheng SB; Wu CC; Lin YL; Huang CC; P'eng FK
    World J Surg Oncol; 2017 Nov; 15(1):194. PubMed ID: 29096656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
    Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
    Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver.
    Wörns MA; Bosslet T; Victor A; Koch S; Hoppe-Lotichius M; Heise M; Hansen T; Pitton MB; Niederle IM; Schuchmann M; Weinmann A; Düber C; Galle PR; Otto G
    Scand J Gastroenterol; 2012 Jun; 47(6):718-28. PubMed ID: 22472070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.